Cargando…
Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
Autores principales: | Künstner, Axel, Schwarting, Julian, Witte, Hanno M., Bernard, Veronica, Stölting, Stephanie, Kusch, Kathrin, Nagarathinam, Kumar, von Bubnoff, Nikolas, Murga Penas, Eva Maria, Merz, Hartmut, Busch, Hauke, Feller, Alfred C., Gebauer, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253119/ https://www.ncbi.nlm.nih.gov/pubmed/35788129 http://dx.doi.org/10.1038/s41408-022-00699-1 |
Ejemplares similares
-
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
por: Witte, Hanno M., et al.
Publicado: (2022) -
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023) -
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
por: Hertel, Nadine, et al.
Publicado: (2021) -
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
por: Künstner, Axel, et al.
Publicado: (2021) -
Blastic plasmacytoid dendritic cell neoplasm
por: Lencastre, André, et al.
Publicado: (2013)